Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders
作者： Wouter Erik Roorda , Paul Consigny , Jin Cheng
DOI:
关键词:
摘要: The present invention is directed to implantable devices (e.g., drug-delivery stents) containing nuclear receptor ligands. ligands may be, inter alia, PPAR or retinoids. also provides for the use of ligand-containing in treating preventing vascular disorders restenosis) and related disorders.
lens.org 参考文章(11)
Carla Taylor, Peter Zahradka, Use of ppar alpha agonists for the treatment of vascular and renal diseases ,(2003)
Tobias Diener, Roland Rohde, Katrin Sternberg, Endovascular implant with an active coating ,(2003)
Pierre E. Signore, Coated surgical patches ,(2002)
Andrea D. Weston, Tulley Michael Underhill, Retinoid receptor pan-antagonists for stimulating chondrogenesis ,(2002)
Wenda Carlyle, Peiwen Cheng, Robert L Cafferata, Peroxisome proliferator-activated receptor gamma ligand eluting medical device ,(2002)
Jonathon Z. Zhao, Robert Falotico, Antithrombotic coating for drug eluting medical devices ,(2006)
Robert Epple, Mihai Azimioara, None, Compounds and compositions as ppar modulators ,(2005)
Orest Olejnik, Patrick M. Hughes, John S. Kent, Implant device with a retinoid for improved biocompatibility ,(2001)
Thangavel Kuberasampath, Charles M. Cohen, David C. Rueger, Hermann Oppermann, Roy H. L. Pang, Protein-induced morphogenesis ,(1992)
Gideon Strassman, Ascher Schmulewicz, Coated intraluminal stents ,(2002)